Lablytica

Lablytica is a specialized Contract Research Organization (CRO) based in Uppsala, Sweden, providing advanced bioanalytical services for the life sciences industry. The company focuses on the analysis of large molecules, including proteins, peptides, and oligonucleotides, utilizing state-of-the-art mass spectrometry and ligand binding assay platforms. Lablytica supports drug development programs from the discovery phase through clinical trials, offering GLP and GCP-compliant services for pharmacokinetic (PK), pharmacodynamic (PD), and biomarker studies. Their expertise helps pharmaceutical and biotech clients navigate complex analytical challenges in the development of biologics and advanced therapies.